Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nuclear Medicine | 4 | 2022 | 261 | 1.810 |
Why?
|
| Receptors, Somatostatin | 2 | 2022 | 138 | 0.870 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2018 | 137 | 0.570 |
Why?
|
| Internship and Residency | 4 | 2022 | 5944 | 0.560 |
Why?
|
| Subcutaneous Fat | 1 | 2018 | 401 | 0.490 |
Why?
|
| Molecular Imaging | 1 | 2020 | 822 | 0.430 |
Why?
|
| Lymph Nodes | 1 | 2022 | 3449 | 0.340 |
Why?
|
| Inpatients | 1 | 2021 | 2564 | 0.330 |
Why?
|
| Fluorodeoxyglucose F18 | 7 | 2021 | 2027 | 0.330 |
Why?
|
| Students, Medical | 1 | 2020 | 1962 | 0.270 |
Why?
|
| Positron-Emission Tomography | 7 | 2022 | 6545 | 0.220 |
Why?
|
| Radiopharmaceuticals | 6 | 2020 | 2700 | 0.220 |
Why?
|
| Sarcoidosis | 2 | 2019 | 534 | 0.200 |
Why?
|
| Ethylene Glycols | 2 | 2019 | 196 | 0.180 |
Why?
|
| Radionuclide Imaging | 2 | 2022 | 1984 | 0.180 |
Why?
|
| Cyclobutanes | 1 | 2020 | 57 | 0.170 |
Why?
|
| Carboxylic Acids | 1 | 2020 | 91 | 0.160 |
Why?
|
| Axilla | 1 | 2022 | 615 | 0.160 |
Why?
|
| Acidosis, Renal Tubular | 1 | 2018 | 50 | 0.150 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 2018 | 150 | 0.140 |
Why?
|
| Career Choice | 2 | 2022 | 769 | 0.140 |
Why?
|
| Cultural Diversity | 1 | 2021 | 370 | 0.140 |
Why?
|
| Aniline Compounds | 2 | 2019 | 1075 | 0.140 |
Why?
|
| Fluorine Radioisotopes | 1 | 2019 | 398 | 0.130 |
Why?
|
| Internationality | 1 | 2021 | 1005 | 0.130 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2015 | 50 | 0.130 |
Why?
|
| Organometallic Compounds | 1 | 2019 | 644 | 0.120 |
Why?
|
| Nephritis | 1 | 2016 | 146 | 0.120 |
Why?
|
| Liver Neoplasms | 2 | 2021 | 4351 | 0.120 |
Why?
|
| Cholecystitis | 1 | 2015 | 181 | 0.120 |
Why?
|
| Salivary Glands | 1 | 2016 | 231 | 0.120 |
Why?
|
| Gallbladder | 1 | 2015 | 308 | 0.110 |
Why?
|
| Lacrimal Apparatus | 1 | 2016 | 224 | 0.110 |
Why?
|
| Schools, Medical | 1 | 2020 | 877 | 0.110 |
Why?
|
| Neoplasms | 1 | 2022 | 22349 | 0.100 |
Why?
|
| Radiography | 2 | 2022 | 6941 | 0.100 |
Why?
|
| Radiology Information Systems | 1 | 2017 | 531 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 9372 | 0.100 |
Why?
|
| Faculty, Medical | 1 | 2020 | 1219 | 0.100 |
Why?
|
| Myocarditis | 1 | 2019 | 801 | 0.090 |
Why?
|
| Amyloidosis | 1 | 2019 | 884 | 0.090 |
Why?
|
| Thoracic Vertebrae | 1 | 2015 | 614 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 4883 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 2741 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2016 | 1181 | 0.080 |
Why?
|
| Respiration | 1 | 2015 | 1652 | 0.080 |
Why?
|
| Humans | 20 | 2022 | 765823 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2021 | 20680 | 0.070 |
Why?
|
| Parotid Gland | 2 | 2019 | 177 | 0.070 |
Why?
|
| Artifacts | 1 | 2015 | 1893 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2021 | 3459 | 0.060 |
Why?
|
| Male | 10 | 2022 | 363740 | 0.060 |
Why?
|
| Stents | 1 | 2015 | 3235 | 0.050 |
Why?
|
| Middle Aged | 8 | 2022 | 223016 | 0.050 |
Why?
|
| Misonidazole | 1 | 2021 | 33 | 0.050 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2021 | 161 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 26276 | 0.040 |
Why?
|
| Kidney Tubules, Distal | 1 | 2018 | 43 | 0.040 |
Why?
|
| Nephrocalcinosis | 1 | 2018 | 51 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 11092 | 0.030 |
Why?
|
| Algorithms | 1 | 2017 | 14062 | 0.030 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2018 | 196 | 0.030 |
Why?
|
| United States | 2 | 2022 | 72896 | 0.030 |
Why?
|
| Growth | 1 | 2018 | 365 | 0.030 |
Why?
|
| Perfusion | 1 | 2021 | 1408 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2018 | 588 | 0.030 |
Why?
|
| Female | 8 | 2021 | 396050 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2019 | 2270 | 0.030 |
Why?
|
| Aged | 7 | 2021 | 171178 | 0.030 |
Why?
|
| Amyloid | 1 | 2019 | 849 | 0.030 |
Why?
|
| Remission Induction | 1 | 2019 | 2410 | 0.030 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2018 | 781 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 4110 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2019 | 2919 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5302 | 0.020 |
Why?
|
| Adult | 5 | 2021 | 223055 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6765 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 5335 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2019 | 8725 | 0.020 |
Why?
|
| Software | 1 | 2019 | 4458 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12966 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2019 | 54798 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14644 | 0.010 |
Why?
|
| Radiology | 1 | 2017 | 2089 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 8927 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2021 | 81505 | 0.010 |
Why?
|
| Lung | 1 | 2019 | 10031 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 9069 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 22227 | 0.010 |
Why?
|
| Time Factors | 1 | 2019 | 40109 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 59506 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 42478 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 59849 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 65223 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 36542 | 0.010 |
Why?
|
| Mutation | 1 | 2018 | 30188 | 0.010 |
Why?
|
| Child | 1 | 2018 | 80509 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 88794 | 0.010 |
Why?
|
Concepts
(98)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(35)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_